thiazolidines has been researched along with Corneal Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujishima, H; Shimazaki, J; Tsubota, K; Yagi, Y | 1 |
| Kador, PF; Kinoshita, JH; Sharpless, NE | 1 |
1 review(s) available for thiazolidines and Corneal Diseases
| Article | Year |
|---|---|
Aldose reductase inhibitors: a potential new class of agents for the pharmacological control of certain diabetic complications.
Topics: Aldehyde Reductase; Animals; Binding Sites; Blood Glucose; Cataract; Chemical Phenomena; Chemistry; Corneal Diseases; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; Disease Models, Animal; Fluorenes; Galactose; Humans; Hydantoins; Imidazoles; Imidazolidines; Models, Molecular; Naphthalenes; Phthalazines; Rhodanine; Sorbitol; Structure-Activity Relationship; Substrate Specificity; Sugar Alcohol Dehydrogenases; Thiazolidines; Tissue Distribution | 1985 |
1 trial(s) available for thiazolidines and Corneal Diseases
| Article | Year |
|---|---|
Improvement of corneal sensation and tear dynamics in diabetic patients by oral aldose reductase inhibitor, ONO-2235: a preliminary study.
Topics: Administration, Oral; Aged; Aldehyde Reductase; Cornea; Corneal Diseases; Diabetes Complications; Diabetes Mellitus; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Rhodanine; Sensation; Tears; Thiazolidines | 1996 |